期刊
VACCINE
卷 27, 期 23, 页码 3072-3082出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2009.03.019
关键词
Vaccine; alpha-Gal glycolipids; Anti-Gal antibody; APC
资金
- NIH [CA722019]
Anti-Gal constitutes similar to 1% of circulating IgG in humans and interacts specifically with alpha-gal epitopes. We reported previously that expression of a-gal epitopes on HIV gp120 and influenza virus vaccines increases immunogenicity by similar to 100-fold. We hypothesize that immunogenicity of any microbial vaccine can be markedly increased by linked a-gal epitopes due to in vivo formation of immune complexes with anti-Gal and the effective internalization of such immune complexes by APC, via Fc/Fc gamma R interaction. The increased transport to lymph nodes and processing of anti-Gal complexed vaccines internalized by APC, results in effective activation of vaccine specific CD4(+) and CD8(+) T cells, and high cellular and humoral immune response. This universal mechanism for anti-Gal mediated increased immunogenicity is demonstrated in alpha 1,3galactosyltransferase knockout mice with ovalbumin as a model vaccine. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据